28 September 2026 in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
Objetivos. Analizar la enseñanza de cardiología en facultades de Medicina Humana del Perú, caracterizar su organización curricular, evaluar la cobertura temática explícitamente documentada e identificar diferencias según el régimen universitario. Materiales y métodos. Estudio documental, transversal y comparativo. Se analizaron los sílabos y documentos académicos correspondientes a la enseñanza de cardiología en 42 facultades de Medicina. Se evaluó la presencia explícita de siete condiciones cardiovasculares y siete categorías de contenido mediante una matriz analítica desarrollada para el estudio. Las comparaciones entre universidades públicas y privadas se realizaron mediante pruebas de chi-cuadrado, exacta de Fisher y U de Mann-Whitney. Resultados. La cardiología se enseñó integrada en Medicina Interna en el 81,0% de las facultades, con una duración de 4 semanas y 16 horas teóricas. La cobertura temática explícitamente documentada promedio fue de 26,7%; tratamiento inicial (42,5%) y diagnóstico (40,1%) fueron los componentes más frecuentes, mientras que epidemiología y prevención presentaron la menor cobertura (17,0% cada una). Las dislipidemias presentaron una cobertura promedio de 3,1%. El coordinador fue cardiólogo en 14/42 facultades (33,3%) y el uso de simuladores fue mayor en universidades privadas que en públicas (p = 0,002). Conclusiones. La enseñanza de cardiología en el pregrado médico peruano mostró heterogeneidad en su organización y una baja cobertura explícitamente documentada de varios contenidos cardiovasculares, particularmente epidemiología y prevención. Estos hallazgos proporcionan una línea de base para orientar el fortalecimiento de contenidos cardiovasculares prioritarios en el pregrado médico peruano.
11 July 2026 in Drugs & Therapy Perspectives
Background and Objective Prolonged intravenous (IV) antibiotics are standard for brain abscess management but prolong hospital stays and increase costs. Intravenous-to-oral switch (IVOS) has been proposed as a safe alternative. This systematic review aimed to assess the effectiveness of IVOS strategies and compare clinical outcomes according to duration of IV exposure prior to oral switch. Methods A systematic review and meta-analysis was conducted according to PRISMA guidelines. Five electronic databases were searched (PubMed, Embase, Scopus, Web of Science, and Cochrane Library) up to May 11, 2025. Eligible studies included retrospective or prospective cohort studies in patients aged ≥ 16 years with brain abscess, reporting at least one predefined clinical outcome. Studies were excluded if they did not evaluate oral antibiotic therapy or did not report extractable outcome data. Outcomes assessed included treatment success (primary), recurrence, adverse events, and hospital stay. Risk of bias was evaluated using the ROBINS-I V2 tool. Exposure thresholds for IV duration were retained as defined within each individual study, given the absence of a uniform protocol across cohorts. Results Five retrospective cohort studies comprising 488 patients were included; four provided sufficient data for meta-analysis. Median time to oral switch ranged from 9 to 19 days (reported in three studies). Overall treatment success was 70.2% (321/457), with 83.2% (154/185) in shorter IV exposure groups and 61.4% (167/272) in longer IV exposure groups (study defined). In pooled analysis, shorter IV exposure (study-defined thresholds) was associated with higher treatment success compared with longer IV exposure (OR 2.69; 95% CI 1.66–4.37; p < 0.001; I2 = 0%); however, exposure thresholds and outcome definitions varied across studies, and the pooled estimate reflects a directional association rather than the effect of a standardized intervention. Sensitivity analysis confirmed robustness, and funnel plot inspection revealed no major publication bias, though this assessment was limited by the small study number. Conclusions IVOS strategies appear to be a safe and potentially effective approach for selected patients with brain abscess, potentially reducing hospitalization without compromising outcomes. Evidence remains limited by retrospective design and moderate-to-serious risk of bias. Prospective trials are warranted. Registration The review was prospectively registered in PROSPERO (CRD420251060028).